Statistics from Altmetric.com
Multicentre randomised controlled trial.
Follow up period:
Fourteen medical centres in North America and Western Europe; time period not reported.
263 people aged 16–40 years with first episode schizophrenic spectrum psychosis (DSM-IV) and active psychotic symptoms. Participants had to have less than five years of symptoms with any recovery period lasting less than six months, and antipsychotic …
For correspondence: Stephen Strakowski, Center for Imaging Research and Division of Bipolar Disorders Research, University of Cincinnati College of Medicine, 231 Albert Sabin Way (ML0583), Cincinnati, OH 45267-0583, USA;
Source of funding: Eli Lilly Research Foundation.